EQUITY |
3 Months Ended |
|---|---|
Mar. 31, 2025 | |
| EQUITY | |
| EQUITY | NOTE 4 – EQUITY
The Company is authorized to issue 100,000,000 shares of common stock with par value of $0.0001 and 20,000,000 shares of preferred stock with par value of $0.0001.
Effective February 1, 2024, FINRA has approved a reverse stock split of our issued and outstanding shares of common stock on a basis of up to thirty (30) old shares for one (1) new share of common stock.
During the three months ended March 31, 2024, convertible note principal amount of $17,645 was converted into 352,900 shares of common stock.
During the three months ended March 31, 2024, 3,500,000 shares of common stock was issued to the Director of the Company for services from March 10, 2024 through March 10, 2024 valued at $175,000.
As of March 31, 2025 and December 31, 2024, there were no preferred stock issued and outstanding.
As of March 31, 2025 and December 31, 2024, there were 4,082,479 shares of common stock issued and outstanding. |